Item 1(a). | Name of Issuer: |
Alignment Healthcare, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
1100 W. Town and Country Road, Suite 1600
Orange, CA 92868
Item 2(a). | Names of Persons Filing: |
This statement is filed by the entities and persons listed below, each of whom is referred to herein as a “Reporting Person” and together as the “Reporting Persons”:
1. Warburg Pincus Private Equity XII, L.P. (“WP XII”)
2. Warburg Pincus Private Equity XII-B, L.P. (“WP XII-B”)
3. Warburg Pincus Private Equity XII-D, L.P. (“WP XII-D”)
4. Warburg Pincus Private Equity XII-E, L.P. (“WP XII-E”)
5. WP XII Partners, L.P. (“WP XII Partners”)
6. Warburg Pincus XII Partners, L.P. (“Warburg Pincus XII Partners,” and, together with WP XII, WP XII-B, WP XII-D, WP XII-E, and WP XII Partners, the “WP XII Funds”)
7. Warburg Pincus LLC (“WP LLC”), a registered investment adviser and the manager of the WP XII Funds
8. Warburg Pincus XII, L.P. (“WP XII GP”), general partner of the WP XII Funds
9. WP Global LLC (“WP Global”), general partner of WP XII GP
10. Warburg Pincus Partners II, L.P. (“WPP II”), managing member of WP Global
11. Warburg Pincus Partners II Holdings, L.P. (“WPP II Holdings”), a limited partner of WPP II
12. Warburg Pincus Partners GP LLC (“WPP GP”), general partner of WPP II and WPP II Holdings
13. Warburg Pincus & Co. (“WP”), managing member of WPP GP
Item 2(b). | Address of the Principal Business Office or, if None, Residence: |
For all Reporting Persons:
450 Lexington Avenue
New York, New York 10017, U.S.A.
See responses to Item 4 on each cover page.
Item 2(d). | Title of Class of Securities: |
Common Stock, $0.01 par value
01625V104
Item 3. | If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a(n): |
Not Applicable.